Patients of cervical and ovarian cancers represent the groups with larger numbers in ZIP11 mutations, however mutations on this gene are not considered to be a prognostic marker of the disease (Figure 1 and Supplementary Figure S1 and Supplementary Table S3). The gene discussed is SLC39A11; the disease is ovarian carcinoma.